Chinese Journal of Hepatology 2007 Issue 9 The influence of resistin on the gene expression of peroxisome proliferator-activated receptor gamma and glucose transporter 2 in human hepatic cells

The influence of resistin on the gene expression of peroxisome proliferator-activated receptor gamma and glucose transporter 2 in human hepatic cells
ZHAO Jia-yong;WANG Yi-fei;LIU Qiu-ying;HU Hong-mei

..............page:703-704

A study of biological characteristics of hepatoma cells with multidrug resistance induced by X-ray
JIANG Ming-dong;PENG Zhi-ping;LI Shao-lin;YIN Xiao-ling

..............page:701-702

An analysis of long term prophylaxis of virus recurrence with antiviral treatment in HBV infected liver transplant recipient patients
DAI Jun;LU Shi-chun;YAN Lü-nan;LI Bo;LAI Wei;ZHAO Ji;JIN Sheng-jie;WEN Tian-fu;ZHAO Ji-chun;ZENG Yong;GU Mei;TAO Chuan-min;ZHANG Xiu-hui

..............page:663-666

A preliminary study of the killing function in vitro by T lymphocytes activated by dendritic cells loaded with exosomes secreted by hepatic cancer cell lines with high or low metastatic potentials
WANG Kai-feng;YE Sheng-long;SONG Li-jie;CUI Jie-feng;WENG Yong-qiang;LIANG Chun-min;SUN Rui-xia;TANG Zhao-you

..............page:658-662

Hypoxia induced by CoCl2 influencing the expression and the activity of matrix metalloproteinase-2 in rat hepatic stellate cells
FAN Ren-hua;CHEN Ping-sheng;ZHAO Di;ZHANG Wan-dong

..............page:654-657

Effects of rosiglitazone on Kruppul-like factor 6(KLF6) signaling in the livers of rats with nonalcoholic fatty liver fibrosis
WANG Xiao-min;CHEN Dong-feng

..............page:649-653

The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai
WAN Yan-ping;XU Ren-ying;FANG Hua;LU Li-ping;ZHANG Xiao-min;CAI Wei

..............page:644-648

Non-alcoholic fatty liver disease: its past, present and future
FAN Jian-gao

..............page:641-643

Expression of HMGB-1 and its extracellular release of cultured primary hepatic parenchymal cells and Kupffer cells induced by LPS
ZHAO Zhong-fu;HAN De-wu;LIU Ming-she;ZHANG Guo-ying;ZHANG Yun;YANG Hui;YANG Liu-xu

..............page:676-680

The effect of endotoxemia on gluconeogenesis in livers and kidneys during acute hepatic failure
ZHU Yong-fen;TIAN De-ying;XU Dong;NI Ming;SONG Pei-hui

..............page:672-675

Detection of CD4+CD25+ regulatory T cells in liver tissues of fibrosing cholestatic hepatitis after liver and kidney transplantation
LANG Zhen-wei;SHEN Bing;ZHANG Liang;SHI Xiao-hong;MA Pei-qing;LAN Meng-dong;MA Zhi-chun;JIN Shu-hua

..............page:667-671

xiao xi

..............page:671,710

du zhe zuo zhe bian zhe

..............page:653,675,686,708,720

Research in diagnosing hepatic fibrosis with serological parameters
YANG Dong-hua;LIU Liu;TANG Shao-hui

..............page:718-720

Significance and determination of chimerism with graft vs host disease after liver transplantation
YAO Gui-ling;LI Wei;MA Xue-ping;WANG Bin

..............page:715-717

A case of dermatomyositis misdiagnosed as viral hepatitis B and D superinfection
DAI Wei-wei;XU Han-feng;YAO Yue-ping

..............page:717

Liver cirrhosis with secondary lymphangiectasia of the small intestine: a case report
ZHANG Yang;WU Xiao-yin

..............page:714

A study of the liver pathology and direct sequencing of all exons of WD gene in a patient with fulminant Wilson disease
HE Gang;YANG Xu;LUO Kai-zhong;JIANG Yong-fang;CHEN Han-chun;LU Shang-wu

..............page:712-713

Establishment and evaluation of a new animal model of nonalcoholic fatty liver disease in mice
XU Lei;XU Cheng-fu;SHI Qiao-juan;YU Chao-hui;LI You-ming

..............page:693-694

Some current issues in the studies of pediatric nonalcoholic fatty liver disease
LOU Guo-qiang;SHI Jun-ping

..............page:691-692

Prognosis of non-alcoholic fatty liver disease
XU You-qing

..............page:689-690

Therapeutics of non-alcoholic fatty liver disease
Vincent Wai-sun WONG;FAN Jian-gao;Henry Lik-yuen CHAN

..............page:687-688

The diagnosis of fatty liver diseases
LI You-ming

..............page:685-686

Effects of bone marrow mesenchymal stem cells on the proliferation of hepatocytes and cirrhotic fat-storing cells in vitro
SHI Li-jun;LI Shuang-xing;SUN Bo;WANG Jing-hua;LI Hu-lun;JIN Lian-hong

..............page:681-684

An analysis of anti-hepatitis antigens in liver biopsy specimens of 20 patients with chronic liver diseases of unknown etiology
ZHOU Xiao-qian;XU Ji-cheng;YOU Guo-qiong

..............page:711

Expression of 24p3 and interleukin-17A in autoimmune hepatitis
HE Bo;GAO Wen-da;SONG Gui-qin;WANG Chen-chen;YANG Ming-li;LIU Quan-sheng

..............page:709-710

Effect of a molecular adsorbent recirculation system on the treatment of severe liver injury patients with hyperthyroidism
ZHANG Lun-li;CHEN Shi-bin;HE Jiang-long;SHI Yu-fei;YANG Xiao-lan;WANG Zhi-hua

..............page:707-708

A case-control study on the association of hepatocellular carcinoma with genetic polymorphisms of CYP3A5 in a highly aflatoxin B1 contaminated Guangxi area
LU Hai-xia;FENG Zhen-bo;FENG Xiao-lan

..............page:705-706

Establishing a predicting model for assessment of early rebleeding following endoscopic esophageal variceal ligation
HAN Tao;XUE Dong-yun;ZHANG Hui-zhen;XIAO Shi-xiang;LI Yan;KAN Zhi-chao;L(U) Hong-min;CHEN Ying

..............page:699-700

Pulmonary aspergillosis in patients with severe hepatitis: it's clinical features and treatments
TIAN Yi;TANG Xiao-peng;LI Hui

..............page:697-698

Percutaneous transhepatic variceal embolization combined with partial splenic embolization in treating gastric and esophageal variceal bleeding
MA Li-ping

..............page:695-696